Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Wo2013171639 asciminib?Asciminib synthesis route patent?Tagrisso osimertinib patent expiration date?What's the mechanism of lipitor in altering protein function for cholesterol regulation?Asciminib patent synthesis?
See the DrugPatentWatch profile for Lialda
Lialda is an oral mesalamine product supplied as tablets (generally described as 1 tablet per dose in typical regimens). The exact tablet dimensions and “pill size” (length/diameter) aren’t provided in the available information here, so you may need to confirm with your specific package insert or by checking the product listing for the exact tablet strength you have.
Lialda comes in different strengths (commonly 1.2 g tablets in the U.S.). Even when the drug name is the same, tablet size can vary by strength and by manufacturer/packaging lot, so the most accurate way to match “pill size” is to look at the exact strength shown on your bottle.
Reply with the strength shown on your Lialda bottle (for example, “1.2 g delayed-release tablets”) and whether it’s the U.S. formulation, and I’ll focus the answer on that specific product.
Other Questions About Lialda :